Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

BIT225 Capsule Formulation Trial Completed

14 August 2013 by Justine Bednorz

BIT225 Capsule Formulation Trial Completed

Categories 2013, ASX Announcements

Patient Enrolment in Phase 2 BIT225 Co-infected Study Completed

Shareholder update – August edition of BITNews

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 30 October 2024 Legal Notices and Privacy